Behcet's disease with uveitis in Taiwan

Journal of the Chinese Medical Association

Volumn 71, Issue 10, 2008, Pages 509-516

  Chung, Yu Mei ^a   Lin, Ying Cheng ^b   Tsai, Chia Chen ^c   Huang, De Feng ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI CITY HOSPITAL   (Taiwan)

^c CHENG HSIN GENERAL HOSPITAL   (Taiwan)

Author keywords

Behcet's disease; Chinese; Taiwan; Uveitis

Indexed keywords

AZATHIOPRINE; CHLORAMBUCIL; COLCHICINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; HLA B51 ANTIGEN; HYDROXYCHLOROQUINE; METHOTREXATE;

ADOLESCENT; ADULT; ARTICLE; BEHCET DISEASE; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DETERIORATION; DIGESTIVE SYSTEM INJURY; DRUG MEGADOSE; DRUG RESPONSE; FEMALE; GENITAL INJURY; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; RISK ASSESSMENT; SEX DIFFERENCE; SKIN DEFECT; TAIWAN; UVEITIS; VISUAL ACUITY; VISUAL IMPAIRMENT;

EID: 56349107479     PISSN: 17264901     EISSN: 17287731     Source Type: Journal    
DOI: 10.1016/S1726-4901(08)70159-X     Document Type: Article

References (30)

1. Verity DH, Marr JE, Ohno S, Wallace GR, Stanford MR. Behcet's disease, the Silk Road and HLA-B51: historical and geographical perspectives. Tissue Antigens 1999;54:213-20.
2. Mok CC, Cheung TC, Ho CTK, Lee KW, Lan CS, Wong RW. Behcet's disease in Southern Chinese patients. J Rheumotol 2002;29:1689-93.
3. Mineshita S, Tian D, Wang LM, Jian XY, Li SY, Fang GZ, Bian TY, et al. Histocompatibility antigens associated with Behcet's disease in northern Han Chinese. Intern Med 1992; 31:1073-5.
4. Geng L, Ohno S, Wang YH, Higuchi M. Clinical observations on Behcet's disease in Tianjin, China. Jpn J Ophthalmol 1985; 29:310-4.
5. Yang P, Zhang Z, Zhou H, Li B, Huang X, Gao Y, Zhu L, et al. Clinical pattern and characteristics of uveitis in a tertiary center for uveitis in China. Curr Eye Res 2005;30:943-8.
6. Chung YM, Yeh TS, Sheu MM, Chen MS, Wen MS, Tsai HY. Behcet's disease with ocular involvement in Taiwan: a joint survey of six major ophthalmological departments. J Formos Med Assoc 1990;89:413-7.
7. Kaklamani VG, Vaiopoulos G, Kaklamains PG. Behcet's disease. Semin Arthritis Rheu 1998;27:197-217.
8. Fresko I. Highlight of the 10th International Congress on Behcet's Disease. Clin Exp Rheumatol 2002;20(Suppl):S59-64.
9. Yoshida A, Kawashima H, Motoyama Y, Shibui H, Kaburaki T, Shimizu K, Ando K, et al. Comparison of patients with Behcet's disease in the 1980s and 1990s. Ophthalmology 2004;111:810-5.
10. Tugal-Tutkun I, Onal S, Altan-Yaycioglu R, Altunbas HH, Urgancioglu AM. Uveitis in Behcet disease: an analysis of 880 patients. Am J Ophthalmol 2004;138:373-80.
11. Suzuki Kurokawa M, Suzuki N. Behcet's disease. Clin Exp Med 2004;4:10-20.
12. Chung YM, Yeh TS, Liu JH. Endogeous uveitis in Chinese: an analysis of 240 cases in a uveitis clinic. Jpn J Ophthalmol 1988;32:64-9.
13. Behcet H. Uber rezidiverende, apthose durch ein Virus verusachte Geschwure am Mund, am auge und an der Genitalen. Dermatol Wochenschr 1937;105:1152-7. [In German]
14. Adamantiades B. Sur un case d'iritis a hypopyon recidivant. Ann Oculist (Paris) 1931;168:271-8. [In French]
15. Feigenbaum A. Description of Behcet's syndrome in Hippocratic third book endemic disease. Br J Ophthalmol 1956;40:355-7.
16. International Study Group for Behcet's Disease. Evaluation of diagnostic (classification) criteria in Behcet's disease: toward internationally agreed criteria. Lancet 1990;335:1078-80.
17. Sakamoto M, Akazawa K, Nishioka Y, Sanui H, Inomata H, Nose Y. Prognostic factors of vision in patients with Behcet disease. Ophthalmology 1995;102:317-21.
18. Muhaya M, Lightman S, Ikeda E, Mochizuki M, Shaer B, McCluskey P, Towler HMA. Behcet's disease in Japan and in Great Britain: a comparative study. Ocul Immunol Inflamm 2000;8:141-8.
19. Ambresin A, Tran T, Spertini F, Herbort C. Behcet's disease in Western Switzerland: epidemiology and analysis of ocular involvement. Ocul Immunol Inflamm 2002;10:53-63.
20. Takeuchi M, Hokama H, Tsukahara R, Kezuka T, Goto H, Sakai JI, Usui M. Risk and prognostic factors of poor visual outcome in Behcet's disease with ocular involvement. Grafes Arch Clin Exp Ophthalmol 2005;243:1147-52.
21. Ando K, Fujino Y, Hijikata K, Izawa Y, Masuda K. Epidemiological features and visual prognosis of Behcet's disease. Jpn J Ophthalmol 1999;43:312-7.
22. Barra C, Belfort R Jr, Abreu MT, Kim MK, Martins MC, Petrilli AM. Behcet's disease in Brazil: a review of 49 cases with emphasis on ophthalmic manifestations. Jpn J Ophthalmol 1991; 35:339-46.
23. Demiroglu H, Barista I, Dundar S. Risk factor assessment and prognosis of eye involvement in Behcet's disease in Turkey. Ophthalmology 1997:104:701-5.
24. Mishima S, Masuda K, Izawa Y, Mochizuki M, Namba K. Behcet's disease in Japan: ophthalmological aspects. Trans Am Ophthalmol Soc 1979;77:225-79.
25. Shaw CK, Chen LL, Lee A, Lee TD. Distribution of HLA gene and haplotype frequencies in Taiwan: a comparative study among Min-nan, Hakka, Aborigines and Mainland Chinese. Tissue Antigens 1999;53:51-64.
26. Matsumura N, Mizushima Y. Leucocyte movement and colchine treatment in Behcet's disease. Lancet 1975;2:813.
27. Yurdakul S, Mat C, Tuzun Y, Ozyazgan Y, Hamuryudan V, Uysal O, Senocak M, et al. A double-blind trial of colchicine in Behcet's syndrome. Arthritis Rheum 2001;44:2686-92.
28. Nussenblatt RB, Palestine AG, Chan CC, Mochizuki M, Yancey K. Effectiveness of cyclosporin therapy for Behcet's disease. Arthritis Rheum 1985;28:671-9.
29. Mamo FG. The rate of visual loss in Behcet's disease. Arch Ophthalmol 1970;84:451-2.
30. BenEzra D, Cohen E. Treatment and visual prognosis in Behcet's disease. Br J Ophthalmol 1986;70:589-92.